Avantor (AVTR)
(Delayed Data from NYSE)
$24.01 USD
-0.06 (-0.25%)
Updated Jun 7, 2024 04:00 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
Avantor, Inc. [AVTR]
Reports for Purchase
Showing records 21 - 40 ( 132 total )
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Life Science Earnings Recap: Three Groups of Opportunity Ahead, One Area of Risk (China)
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
2Q Misses Estimates, Lower Guide, EBITDA/Cash Flow Bright Spot
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
2Q23 - Guidance Down but Not Really a Set of Unique Issues
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
1Q23 - An Improving Setup with Higher EPS and Rising Free Cash
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Provider: Zacks Investment Research
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
2023 KBCM Life Sciences & MedTech Forum: Day 1 Takeaways
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
4Q22 Beats; Bioprocess Business Driving LT Growth and FY23 Guidance
Provider: KeyBanc Capital Markets
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
4Q22 Earnings and FY23 Guidance, Mostly Beating Expectations with BioProcess Driving Upside
Provider: KeyBanc Capital Markets
Analyst: Research Department